American International Group, Inc. Instil Bio, Inc. Transaction History

American International Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.6 - $0.91 $400 - $607	668 Added 2.03%	33,585 $22,000
Q4 2022 Feb 10, 2023	SELL	$0.48 - $5.33 $57 - $639	-120 Reduced 0.36%	32,917 $20,000
Q3 2022 Nov 14, 2022	BUY	$4.65 - $7.37 $2,171 - $3,441	467 Added 1.43%	33,037 $160,000
Q2 2022 Aug 12, 2022	BUY	$4.21 - $11.15 $24,102 - $63,833	5,725 Added 21.33%	32,570 $150,000
Q1 2022 May 13, 2022	SELL	$8.48 - $18.1 $16,027 - $34,209	-1,890 Reduced 6.58%	26,845 $289,000
Q4 2021 Feb 11, 2022	BUY	$15.37 - $22.5 $291,584 - $426,847	18,971 Added 194.3%	28,735 $492,000
Q3 2021 Nov 12, 2021	SELL	$15.05 - $23.28 $30 - $46	-2 Reduced 0.02%	9,764 $175,000
Q2 2021 Aug 13, 2021	BUY	$15.31 - $24.63 $149,517 - $240,536	9,766 New	9,766 $189,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.67B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.